If you suddenly feel short of breath and a bit anxious, it might be something called "dyspnea." Let's dive into what the ...

Short-term HRV is significantly associated with poor daytime psychomotor vigilance performance among both men and women with ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...

It’s important to get adequate sleep, but you also want to ensure you’re getting restorative sleep. Investing in a sleep tracker is a great way to figure out whether you’re getting quality ...

and Gal-475 for the treatment of sleep apnea syndromes. The company also manufactures preclinical phase products. It offers treatments for other therapeutic areas such as Parkinson’s disease, and ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

Read more. Samsung receives FDA authorization for sleep apnea feature on Galaxy Watch Samsung Electronics has received de novo authorization from the FDA for its sleep apnea feature on the Samsung ...

This article presents evidence that he suffered from obstructive sleep apnea, manifested by excessive daytime somnolence, snoring, systemic hypertension and, perhaps, cognitive and psychosocial ...

Short sleepers cruise by on four to six hours a night and don’t seem to suffer ill effects Marla Broadfoot, Knowable Magazine Some people are genetically built to require less sleep than the ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...